Skip to main content

TRIM38 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon5 and 7 bp deletion in exon5.

Be the first to review this product! Submit a review

Images

Sanger Sequencing - Human TRIM38 knockout A549 cell lysate (AB259208), expandable thumbnail
  • Sanger Sequencing - Human TRIM38 knockout A549 cell lysate (AB259208), expandable thumbnail

Key facts

Cell type
A549
Species or organism
Human
Tissue
Lung
Knockout validation
Sanger Sequencing
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon5 and 7 bp deletion in exon5.

Alternative names

What's included?

1 Kit
Components
Human TRIM38 knockout A549 cell lysate
1 x 100 µg
Human wild-type A549 cell lysate
1 x 100 µg

Recommended products

TRIM38 KO cell lysate available now. Free of charge wild type control included. Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon5 and 7 bp deletion in exon5.

Key facts

Cell type
A549
Mutation description
Knockout achieved by using CRISPR/Cas9, 1 bp insertion in exon5 and 7 bp deletion in exon5.
Disease
Carcinoma
Concentration
Loading...

Properties

Gene name
TRIM38
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing

Quality control

STR analysis
CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level
EU: 1 US: 1
Adherent/suspension
Adherent
Gender
Male

Storage

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
-20°C

Notes


Knockout cell lysate achieved by CRISPR/Cas9.

Abcam has not and does not intend to apply for the REACH Authorisation of customers' uses of products that contain European Authorisation list (Annex XIV) substances.
It is the responsibility of our customers to check the necessity of application of REACH Authorisation, and any other relevant authorisations, for their intended uses.

Lysate preparation: Our lysates are made using RIPA buffer to which we add a protease inhibitor cocktail and phosphatase inhibitor cocktail (ratio: 300:100:10). This means that the protein of interest is denatured. If you require a native form of the protein please use the live cell version. Please refer to our lysis protocol for further details on how our lysates are prepared.

User storage instructions: Lyophilizate may be stored at 4°C. After reconstitution, store at -20°C for short-term storage or -80°C for long-term storage.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

Supplementary info

This supplementary information is collated from multiple sources and compiled automatically.
Activity summary

TRIM38 also known as RNF15 is a member of the tripartite motif family characterized by its RING B-box and coiled-coil domains. It has a molecular mass of approximately 58 kDa. The structure of these domains suggests it functions in protein ubiquitination. TRIM38 is expressed in various tissues with notable expression in the immune system and skeletal tissues. Through these domains TRIM38 can mediate protein-protein interactions and potentially influence protein stability.

Biological function summary

The TRIM38 protein modulates immune responses. It does not form part of a complex but can act independently to regulate inflammatory signals. By targeting signaling proteins for ubiquitination TRIM38 plays a role in innate immunity influencing the production of inflammatory cytokines. This function is essential for keeping the immune response balanced and preventing excessive inflammation that can lead to tissue damage.

Pathways

TRIM38 influences the NF-kB and type I interferon pathways. These pathways are important in immune response modulation. In the NF-kB pathway TRIM38 controls the degradation of particular inhibitor proteins allowing the activation of this transcription factor which regulates genes involved in immune and inflammatory responses. TRIM38 also shares pathway interactions with proteins like TRAF6 and NEMO which contribute to its role in controlling the magnitude of these signaling cascades.

Associated diseases and disorders

TRIM38 has associations with autoimmune diseases and inflammatory conditions. Abnormal regulation of its ubiquitination function can contribute to the pathogenesis of conditions like rheumatoid arthritis and systemic lupus erythematosus. In these diseases TRIM38's interaction with proteins like TRAF6 and interferon regulatory factors becomes imbalanced potentially leading to chronic inflammation and autoimmunity. Understanding TRIM38's role could provide insights for therapeutic interventions in related disorders.

Product promise

We are dedicated to supporting your work with high quality reagents and we are here for you every step of the way should you need us.

In the unlikely event of one of our products not working as expected, you are covered by our product promise.

Full details and terms and conditions can be found here:
Terms & Conditions.

2 product images

  • Sanger Sequencing - Human TRIM38 knockout A549 cell lysate (ab259208), expandable thumbnail

    Sanger Sequencing - Human TRIM38 knockout A549 cell lysate (ab259208)

    Allele-2: 1 bp insertion in exon5

  • Sanger Sequencing - Human TRIM38 knockout A549 cell lysate (ab259208), expandable thumbnail

    Sanger Sequencing - Human TRIM38 knockout A549 cell lysate (ab259208)

    Allele-1: 7 bp deletion in exon5

Downloads

Product protocols

For this product, it's our understanding that no specific protocols are required. You can:

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com